140 related articles for article (PubMed ID: 3550288)
1. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease.
Samoszuk M; Sholly S; Epstein AL
Lab Invest; 1987 Apr; 56(4):394-400. PubMed ID: 3550288
[TBL] [Abstract][Full Text] [Related]
2. Extensive deposition of eosinophil peroxidase in Hodgkin's and non-Hodgkin's lymphomas.
Samoszuk MK; Nathwani BN; Lukes RJ
Am J Pathol; 1986 Dec; 125(3):426-9. PubMed ID: 3799814
[TBL] [Abstract][Full Text] [Related]
3. Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas.
Samoszuk MK; Nguyen V; Gluzman I; Pham JH
Am J Pathol; 1996 Mar; 148(3):701-6. PubMed ID: 8774125
[TBL] [Abstract][Full Text] [Related]
4. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic granuloma of the bone in Hand-Schüller-Christian disease: extensive in vivo eosinophil degranulation and subsequent binding of released eosinophil peroxidase (EPO) to other inflammatory cells.
Zabucchi G; Soranzo MR; Menegazzi R; Cattin L; Vecchio M; Lanza F; Patriarca P
J Pathol; 1991 Mar; 163(3):225-31. PubMed ID: 1707451
[TBL] [Abstract][Full Text] [Related]
6. In-vitro sensitivity of Hodgkin's disease to hydrogen peroxide toxicity. Correlation with peroxidase activity.
Samoszuk MK; Rietveld C; Gidanian F; Petersen A
Cancer; 1989 Jun; 63(11):2111-4. PubMed ID: 2541883
[TBL] [Abstract][Full Text] [Related]
7. Extracellular release of rat eosinophil peroxidase (EPO) I. Role of anaphylactic immunoglobulins.
Khalife J; Capron M; Grzych JM; Bazin H; Capron A
J Immunol; 1985 Mar; 134(3):1968-74. PubMed ID: 3968436
[TBL] [Abstract][Full Text] [Related]
8. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
9. IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease.
Samoszuk M; Ramzi E
Leuk Lymphoma; 1993 Mar; 9(4-5):315-9. PubMed ID: 8348067
[TBL] [Abstract][Full Text] [Related]
10. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunodetection of degranulated human eosinophils in mice: a potential model for imaging Hodgkin's disease and other pathologic conditions.
Samoszuk MK; Fang M; Anderson AL
J Nucl Med; 1991 Jan; 32(1):89-94. PubMed ID: 1988642
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil peroxidase levels in hearts and lungs of mice infected with Toxocara canis.
Dimayuga E; Stober M; Kayes SG
J Parasitol; 1991 Jun; 77(3):461-6. PubMed ID: 1953850
[TBL] [Abstract][Full Text] [Related]
13. Human eosinophil peroxidase: purification and characterization.
Carlson MG; Peterson CG; Venge P
J Immunol; 1985 Mar; 134(3):1875-9. PubMed ID: 3918110
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
Pinkus GS; Lones M; Shintaku IP; Said JW
Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
[TBL] [Abstract][Full Text] [Related]
15. Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease.
Butterfield JH; Kephart GM; Banks PM; Gleich GJ
Blood; 1986 Dec; 68(6):1250-6. PubMed ID: 3535925
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays.
Hedvat CV; Jaffe ES; Qin J; Filippa DA; Cordon-Cardo C; Tosato G; Nimer SD; Teruya-Feldstein J
Mod Pathol; 2001 Dec; 14(12):1270-6. PubMed ID: 11743050
[TBL] [Abstract][Full Text] [Related]
18. Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's disease.
Ben-Ezra J; Sheibani K; Swartz W; Stroup R; Traweek ST; Kezirian J; Rappaport H
Hum Pathol; 1989 Dec; 20(12):1181-5. PubMed ID: 2591947
[TBL] [Abstract][Full Text] [Related]
19. Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease.
Kadin M; Butmarc J; Elovic A; Wong D
Am J Pathol; 1993 Jan; 142(1):11-6. PubMed ID: 8424449
[TBL] [Abstract][Full Text] [Related]
20. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
